ALPS ETF Trust has recently submitted its NPORT-P report, providing a detailed overview of its financial status as of August 31, 2026. This filing is significant as it reveals the company's total assets amounting to approximately $3 billion, showcasing its position in the investment management sector.
Founded in Denver, ALPS ETF Trust is an investment entity that specializes in managing exchange-traded funds (ETFs). The company operates under the SEC file number 811-22175 and is recognized for its innovative investment strategies. The latest filing, dated October 29, 2026, is part of a series of NPORT-P submissions made on the same day, indicating an active reporting period.
The NPORT-P filing highlights several key financial metrics. The total assets reported are approximately $3,017,132,199.51, with total liabilities recorded at $1,502,557.18. This results in net assets of about $3,015,629,642.33. Such figures reflect the fund's strong financial health and effective asset management practices.
Among the investments listed, ALPS ETF Trust holds a diverse portfolio, including significant holdings in Fannie Mae and PNC Financial Services. The report details various securities, including U.S. Treasury bonds and government-backed mortgage securities, which are essential for maintaining a balanced risk profile.
This filing may affect various stakeholders, including investors, analysts, and competitors in the investment management industry. Investors will be particularly interested in the fund's performance metrics and asset allocation strategies, while competitors may analyze this data to benchmark their own performance.
Looking ahead, the filing does not specify what actions will follow this report. However, the continued submission of NPORT-P filings indicates that ALPS ETF Trust is committed to maintaining transparency and providing regular updates to its stakeholders.
Read Next
Jefferies CEO Handler Reports Stock Transactions in SEC Filing
Brophy Michael Burkes sells 3,084 shares of Natera stock
Glenbrook Capital Management Boosts Stake in SenesTech
OS Therapies grants stock options to Chief Medical Officer
Belite Bio CEO Lin Yu-Hsin Vests 5,000 Shares
Chen Wan-Shan Reports Share Transaction for Belite Bio






